{
  "trial_id": "NCT01086540",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), duration of systemic sclerosis, mean pulmonary arterial pressure, mean pulmonary vascular resistance, 6-minute walking distance (6MWD), New York Heart Association (NYHA) Functional Class, oxygen saturation at rest, background medical therapy for PAH, vaccination status, systolic blood pressure (SBP), pulmonary capillary wedge pressure, left ventricular end diastolic pressure, history of coronary artery disease, history of ventricular tachy-arrhythmia, history of stent placement, history of coronary artery bypass surgery, history of myocardial infarction, presence of interstitial lung disease, chronic infections status, hepatitis B or C serology, tuberculosis (TB) test results, renal function, history of SSc renal crisis, recent immunization status, history of anaphylaxis or IgE-mediated hypersensitivity, pregnancy status, lactation status, history of malignancy, compliance with medical therapies, history of alcohol or drug abuse, investigational drug or device use, lung transplant status, transaminase levels, bilirubin levels, absolute neutrophil count, platelet count, hemoglobin levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Six Minute Walk Test Distance (Meters)",
          "6-minute walking distance (6MWD)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of systemic sclerosis",
        "mean pulmonary arterial pressure",
        "mean pulmonary vascular resistance",
        "New York Heart Association (NYHA) Functional Class",
        "oxygen saturation at rest",
        "background medical therapy for PAH",
        "vaccination status",
        "systolic blood pressure (SBP)",
        "pulmonary capillary wedge pressure",
        "left ventricular end diastolic pressure",
        "history of coronary artery disease",
        "history of ventricular tachy-arrhythmia",
        "history of stent placement",
        "history of coronary artery bypass surgery",
        "history of myocardial infarction",
        "presence of interstitial lung disease",
        "chronic infections status",
        "hepatitis B or C serology",
        "tuberculosis (TB) test results",
        "renal function",
        "history of SSc renal crisis",
        "recent immunization status",
        "history of anaphylaxis or IgE-mediated hypersensitivity",
        "pregnancy status",
        "lactation status",
        "history of malignancy",
        "compliance with medical therapies",
        "history of alcohol or drug abuse",
        "investigational drug or device use",
        "lung transplant status",
        "transaminase levels",
        "bilirubin levels",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin levels"
      ]
    },
    "processed-gen-response": "Age, sex, race, body mass index (BMI), duration of systemic sclerosis, mean pulmonary arterial pressure, mean pulmonary vascular resistance, 6-minute walking distance (6MWD), New York Heart Association (NYHA) Functional Class, oxygen saturation at rest, background medical therapy for PAH, vaccination status, systolic blood pressure (SBP), pulmonary capillary wedge pressure, left ventricular end diastolic pressure, history of coronary artery disease, history of ventricular tachy-arrhythmia, history of stent placement, history of coronary artery bypass surgery, history of myocardial infarction, presence of interstitial lung disease, chronic infections status, hepatitis B or C serology, tuberculosis (TB) test results, renal function, history of SSc renal crisis, recent immunization status, history of anaphylaxis or IgE-mediated hypersensitivity, pregnancy status, lactation status, history of malignancy, compliance with medical therapies, history of alcohol or drug abuse, investigational drug or device use, lung transplant status, transaminase levels, bilirubin levels, absolute neutrophil count, platelet count, hemoglobin levels."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Systemic Sclerosis, Baseline 6-minute Walk Distance, New York Heart Association (NYHA) Functional Class, Mean Pulmonary Arterial Pressure, Pulmonary Vascular Resistance, Oxygen Saturation, Background PAH Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Six Minute Walk Test Distance (Meters)",
          "Baseline 6-minute Walk Distance"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Duration of Systemic Sclerosis",
        "New York Heart Association (NYHA) Functional Class",
        "Mean Pulmonary Arterial Pressure",
        "Pulmonary Vascular Resistance",
        "Oxygen Saturation",
        "Background PAH Therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Systemic Sclerosis, Baseline 6-minute Walk Distance, New York Heart Association (NYHA) Functional Class, Mean Pulmonary Arterial Pressure, Pulmonary Vascular Resistance, Oxygen Saturation, Background PAH Therapy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, SSc disease duration, PAH disease duration, NYHA functional class, 6-minute walk distance, Mean pulmonary arterial pressure, Pulmonary vascular resistance, Systolic blood pressure, Diastolic blood pressure, Oxygen saturation, Body mass index, Forced vital capacity, Diffusion capacity of the lungs for carbon monoxide.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Six Minute Walk Test Distance (Meters)",
          "6-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "SSc disease duration",
        "PAH disease duration",
        "NYHA functional class",
        "Mean pulmonary arterial pressure",
        "Pulmonary vascular resistance",
        "Systolic blood pressure",
        "Diastolic blood pressure",
        "Oxygen saturation",
        "Body mass index",
        "Forced vital capacity",
        "Diffusion capacity of the lungs for carbon monoxide"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, SSc disease duration, PAH disease duration, NYHA functional class, 6-minute walk distance, Mean pulmonary arterial pressure, Pulmonary vascular resistance, Systolic blood pressure, Diastolic blood pressure, Oxygen saturation, Body mass index, Forced vital capacity, Diffusion capacity of the lungs for carbon monoxide."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), New York Heart Association (NYHA) Functional Class, mean pulmonary arterial pressure, mean pulmonary vascular resistance, 6-minute walking distance, oxygen saturation at rest, systemic sclerosis subtype (limited or diffuse cutaneous disease), duration of systemic sclerosis, duration of pulmonary arterial hypertension, background medical therapy for PAH.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Six Minute Walk Test Distance (Meters)",
          "6-minute walking distance"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "New York Heart Association (NYHA) Functional Class",
        "mean pulmonary arterial pressure",
        "mean pulmonary vascular resistance",
        "oxygen saturation at rest",
        "systemic sclerosis subtype (limited or diffuse cutaneous disease)",
        "duration of systemic sclerosis",
        "duration of pulmonary arterial hypertension",
        "background medical therapy for PAH."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), New York Heart Association (NYHA) Functional Class, mean pulmonary arterial pressure, mean pulmonary vascular resistance, 6-minute walking distance, oxygen saturation at rest, systemic sclerosis subtype (limited or diffuse cutaneous disease), duration of systemic sclerosis, duration of pulmonary arterial hypertension, background medical therapy for PAH."
  }
}